Cargando…
Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
OBJECTION: The psychological health of thyroid cancer patients cannot be ignored; however, few studies have been conducted on the psychological status and influencing factors of thyroid cancer patients before radioactive iodine (RAI) therapy. The aim of this study was to investigate the incidence an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631608/ https://www.ncbi.nlm.nih.gov/pubmed/36326909 http://dx.doi.org/10.1007/s00520-022-07422-7 |
_version_ | 1784823850461036544 |
---|---|
author | Qiao, Tingting Gao, Dingwei Tong, Junyu Shen, Yun Ma, Jiayue Lv, Zhongwei Li, Dan |
author_facet | Qiao, Tingting Gao, Dingwei Tong, Junyu Shen, Yun Ma, Jiayue Lv, Zhongwei Li, Dan |
author_sort | Qiao, Tingting |
collection | PubMed |
description | OBJECTION: The psychological health of thyroid cancer patients cannot be ignored; however, few studies have been conducted on the psychological status and influencing factors of thyroid cancer patients before radioactive iodine (RAI) therapy. The aim of this study was to investigate the incidence and risk factors for anxiety and depression in thyroid cancer patients prior to RAI therapy. METHODS: Clinical data were collected from patients with differentiated thyroid cancer (DTC) patients preparing for RAI therapy. Anxiety and depression were measured before RAI therapy using the Generalized Anxiety Disorder Questionnaire (GAD-7) and Patient Health Questionnaire (PHQ-9). We used the chi-square test and logistic regression analysis to identify independent risk factors for anxiety and depression. RESULTS: A total of 112 patients with thyroid cancer were included. Of these, 72.32% (n = 81) were female, with a mean age of 41.50 years. Anxiety and depression were reported by 46 (41.08%) and 38 (33.93%) patients, respectively. Based on the chi-square test and univariate logistic regression analysis, being female and having ever-experienced RAI therapy were significant risk factors for anxiety and depression among DTCs prior to RAI therapy. On multivariable analysis, the results of model 2 which included age, sex, education level, and ever suffering radioactive iodine therapy showed that being female was markedly associated with anxiety and depression in these patients, while having ever undergone RAI therapy was significantly related to anxiety but not depression. CONCLUSIONS: The incidence of anxiety and depression among patients with DTC prior to RAI therapy were 41.08% and 33.93%, respectively. Being female and having ever experienced RAI therapy significantly influenced anxiety and depression. Based on these findings, anxiety and depression assessment should be an important part of pre-RAI therapy in patients with DTC, and appropriate psychological nursing intervention can be carried out for key patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-022-07422-7. |
format | Online Article Text |
id | pubmed-9631608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-96316082022-11-03 Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic Qiao, Tingting Gao, Dingwei Tong, Junyu Shen, Yun Ma, Jiayue Lv, Zhongwei Li, Dan Support Care Cancer Research OBJECTION: The psychological health of thyroid cancer patients cannot be ignored; however, few studies have been conducted on the psychological status and influencing factors of thyroid cancer patients before radioactive iodine (RAI) therapy. The aim of this study was to investigate the incidence and risk factors for anxiety and depression in thyroid cancer patients prior to RAI therapy. METHODS: Clinical data were collected from patients with differentiated thyroid cancer (DTC) patients preparing for RAI therapy. Anxiety and depression were measured before RAI therapy using the Generalized Anxiety Disorder Questionnaire (GAD-7) and Patient Health Questionnaire (PHQ-9). We used the chi-square test and logistic regression analysis to identify independent risk factors for anxiety and depression. RESULTS: A total of 112 patients with thyroid cancer were included. Of these, 72.32% (n = 81) were female, with a mean age of 41.50 years. Anxiety and depression were reported by 46 (41.08%) and 38 (33.93%) patients, respectively. Based on the chi-square test and univariate logistic regression analysis, being female and having ever-experienced RAI therapy were significant risk factors for anxiety and depression among DTCs prior to RAI therapy. On multivariable analysis, the results of model 2 which included age, sex, education level, and ever suffering radioactive iodine therapy showed that being female was markedly associated with anxiety and depression in these patients, while having ever undergone RAI therapy was significantly related to anxiety but not depression. CONCLUSIONS: The incidence of anxiety and depression among patients with DTC prior to RAI therapy were 41.08% and 33.93%, respectively. Being female and having ever experienced RAI therapy significantly influenced anxiety and depression. Based on these findings, anxiety and depression assessment should be an important part of pre-RAI therapy in patients with DTC, and appropriate psychological nursing intervention can be carried out for key patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-022-07422-7. Springer Berlin Heidelberg 2022-11-03 2022 /pmc/articles/PMC9631608/ /pubmed/36326909 http://dx.doi.org/10.1007/s00520-022-07422-7 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Qiao, Tingting Gao, Dingwei Tong, Junyu Shen, Yun Ma, Jiayue Lv, Zhongwei Li, Dan Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic |
title | Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic |
title_full | Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic |
title_fullStr | Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic |
title_full_unstemmed | Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic |
title_short | Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic |
title_sort | anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the covid‑19 pandemic |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631608/ https://www.ncbi.nlm.nih.gov/pubmed/36326909 http://dx.doi.org/10.1007/s00520-022-07422-7 |
work_keys_str_mv | AT qiaotingting anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic AT gaodingwei anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic AT tongjunyu anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic AT shenyun anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic AT majiayue anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic AT lvzhongwei anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic AT lidan anxietyanddepressionstatuspriortoradioactiveiodinetherapyamongdifferentiatedthyroidcancerpatientsduringthecovid19pandemic |